Next Article in Journal
Hormone Replacement Therapy and Outcomes for Women with Non-Small-Cell Lung Cancer: Can An Association be Confirmed?
Previous Article in Journal
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Screening for Prostate Cancer: Controversy? What Controversy?

Department of Immunobiology, University of Arizona College of Medicine, PO Box 245221, Tucson, AZ 85724, USA
The Robert Benjamin Ablin Foundation for Cancer Research, Tucson, AZ, USA
Author to whom correspondence should be addressed.
Curr. Oncol. 2009, 16(3), 1-2;
Submission received: 5 February 2009 / Revised: 5 March 2009 / Accepted: 2 April 2009 / Published: 1 May 2009


Note: In lieu of an abstract, this is an excerpt from the first page.

The purpose of screening is to identify preclinical and asymptomatic cases of a disease in a population at risk—as opposed to making a diagnosis based on a patient’s presentation with symptoms and disease. [...]

Share and Cite

MDPI and ACS Style

Ablin, R.J.; Haythorn, M.R. Screening for Prostate Cancer: Controversy? What Controversy? Curr. Oncol. 2009, 16, 1-2.

AMA Style

Ablin RJ, Haythorn MR. Screening for Prostate Cancer: Controversy? What Controversy? Current Oncology. 2009; 16(3):1-2.

Chicago/Turabian Style

Ablin, Richard J., and M. R. Haythorn. 2009. "Screening for Prostate Cancer: Controversy? What Controversy?" Current Oncology 16, no. 3: 1-2.

Article Metrics

Back to TopTop